Sign in
CompletedNo phase

Comparison Between Variable Time Regimen of Dosing L-Thyroxine for Treatment Hypothyroid Fasting Ramadan

Key facts

Who runs it
Sohag University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
89 people enrolled
Started
25 Apr 2023
Ended
30 Jun 2024
Type of study
Observational, 3 groups
Record updated
12 August 2024

Who can take part

Age
20 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • All included patients will be euthyroid, and stable on the same L T4 dose for at least 3 months before the start of Ramadan

Who cannot take part

  • Exclusion criteria will be thyroid cancer patients requiring suppressive therapy, central hypothyroidism, pregnancy, coronary heart disease, arrythmia, chronic heart failure, liver cirrhosis, renal failure, acute medical, or surgical illness at the time of evaluation to avoid acute and chronic non thyroidal illness syndromes

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a study aiming to report the effect of a variable time regimen of L T4 during Ramadan, as an easier alternative, on adherence and thyroid status after Ramadan compared to standard daily dosing.

The 3 groups in the trial

  • Group 1

    .patients who will switch to twice weekly dosing. Their weekly dose was divided equally into those doses, given at successive fixed days of the week

  • Group 2

    patients who will switch to once-weekly dosing.

  • Group 3

    patients who will continue to take L T4 on a standard daily basis.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
12 August 2024